News, features, and commentary about cancer-related issues
— News, features, and commentary about cancer-related issues
June 5, 2026
• 2 min read
A large Danish study suggests that aspirin use may indirectly help uncover asymptomatic bladder cancer. (Journal of Internal Medicine)
A concerning number of deaths and lack of survival benefit in a confirmatory trial have raised questions about the approval status for the antibody-drug conjugate loncastuximab tesirine (Zynlonta) in diffuse large B-cell lymphoma. (BioSpace)
Removing ‘invisibility cloaks’ and safely skipping chemo: new weapons in war on cancer shared at US conference
ImmunityBio Presents New Clinical and Comparative Data Across Lung and Bladder Cancer at ASCO 2026
ASCO ‘26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer
At ASCO, talk of barriers to cancer care, new treatments, and other big takeaways
Abivax ulcerative colitis drug shows strong efficacy, but cases of cancer raise concerns
Pharmalittle: We're reading about pancreatic and lung cancer drugs, China biotech growth, and more
ASCO: Sac-TMT’s massive phase 3 program has a jarring gap. Does Merck plan to close it?
A turning point for pancreatic cancer patients
ASCO26: Blood cancer readouts take centre stage - Pharmaceutical Technology
A standing ovation for RevMed, and caution for Akeso
Strong results from GSK's hepatitis B drug, engineered heart patches, and more biotech news from The Readout
Drug that stops cancer cells hiding and a breakthrough pill for pancreatic cancer among highlights from Asco conference – but…
ASCO, Day 2: promising news around lung cancer, new immunotherapies, and bold words from Rick Pazdur.
Merck-Kelun ADC outperforms Keytruda in trial, a closely watched Parkinson’s drug fails, and more biotech news from The Readout
Bladder cancer is the ninth most common cancer in the world, the fourth most common cancer in men, and the 11th most common…
News, features, and commentary about cancer-related issues
